Hearing on "Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule"
Date:
Location:
John D. Dingell Room, 2123 Rayburn House Office Building
The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Thursday, March 21, 2024, at 10 a.m. in the John D. Dingell Hearing Room, 2123 Rayburn House Office Building. The hearing is entitled, “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.”
Key Documents
Opening Statement from Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee on Health Ranking Member Eshoo as prepared for delivery
Livestream
Witnesses
Jeff Allen, PhD
President and CEO
Friends of Cancer Research
Dara L. Aisner, MD, PhD
Medical Director, Colorado Molecular Correlates Laboratory
Professor of Pathology, University of Colorado
Representative of the Academic Coalition for Effective Laboratory Developed Tests
Donald S. Karcher, MD, FCAP
President
College of American Pathologists (CAP)
Zach Rothstein, JD
Executive Director
AdvaMedDx
Subcommittees
Issues:Health